• Media type: E-Article
  • Title: Influence of Deceased Donor and Pretransplant Recipient Parameters on Early Overall Kidney Graft-Survival in Germany
  • Contributor: Fischer-Fröhlich, Carl-Ludwig; Kutschmann, Marcus; Feindt, Johanna; Schmidtmann, Irene; Kirste, Günter; Frühauf, Nils R.; Wirges, Ulrike; Rahmel, Axel; Schleicher, Christina
  • imprint: Hindawi Limited, 2015
  • Published in: Journal of Transplantation
  • Language: English
  • DOI: 10.1155/2015/307230
  • ISSN: 2090-0007; 2090-0015
  • Keywords: General Medicine
  • Origination:
  • Footnote:
  • Description: <jats:p><jats:italic>Background</jats:italic>. Scarcity of grafts for kidney transplantation (KTX) caused an increased consideration of deceased donors with substantial risk factors. There is no agreement on which ones are detrimental for overall graft-survival. Therefore, we investigated in a nationwide multicentre study the impact of donor and recipient related risks known before KTX on graft-survival based on the original data used for allocation and graft acceptance.<jats:italic>Methods</jats:italic>. A nationwide deidentified multicenter study-database was created of data concerning kidneys donated and transplanted in Germany between 2006 and 2008 as provided by the national organ procurement organization (Deutsche Stiftung Organtransplantation) and BQS Institute. Multiple Cox regression (significance level 5%, hazard ratio [95% CI]) was conducted (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4411</mml:mn></mml:math>, isolated KTX).<jats:italic>Results</jats:italic>. Risk factors associated with graft-survival were donor age (1.020 [1.013–1.027] per year), donor size (0.985 [0.977–0.993] per cm), donor’s creatinine at admission (1.002 [1.001–1.004] per<jats:italic>µ</jats:italic>mol/L), donor treatment with catecholamine (0.757 [0.635–0.901]), and reduced graft-quality at procurement (1.549 [1.217–1.973]), as well as recipient age (1.012 [1.003–1.021] per year), actual panel reactive antibodies (1.007 [1.002–1.011] per percent), retransplantation (1.850 [1.484–2.306]), recipient’s cardiovascular comorbidity (1.436 [1.212–1.701]), and use of IL2-receptor antibodies for induction (0.741 [0.619–0.887]).<jats:italic>Conclusion</jats:italic>. Some donor characteristics persist to impact graft-survival (e.g., age) while the effect of others could be mitigated by elaborate donor-recipient match and care.</jats:p>
  • Access State: Open Access